TY - JOUR KW - Bacterial Vaccines KW - Humans KW - Leprostatic Agents KW - leprosy KW - Mycobacterium leprae KW - Research KW - World Health Organization AU - Kurlberg G AB -
Clinical, bacteriological and immunological research into leprosy is pursued at the Anandaban Leprosy Hospital on the outskirts of Kathmandu in Nepal with support from the World Health Organization and research laboratories in inter alia Holland and Australia. The bacteriological part consists of research into cultivation procedures on mice for diagnosis of Mycobacterium Leprae resistance to dapsone and rifampicin. Serological studies have also yielded M. Leprae-specific antibodies, a method which, it is hoped, will be further developed as an aid to diagnosis and follow-up of treatment. Research concerning a leprosy vaccine is also in progress.
BT - Nordisk medicin C1 - http://www.ncbi.nlm.nih.gov/pubmed/2270200?dopt=Abstract DA - 1990 IS - 12 J2 - Nord Med LA - swe N2 -Clinical, bacteriological and immunological research into leprosy is pursued at the Anandaban Leprosy Hospital on the outskirts of Kathmandu in Nepal with support from the World Health Organization and research laboratories in inter alia Holland and Australia. The bacteriological part consists of research into cultivation procedures on mice for diagnosis of Mycobacterium Leprae resistance to dapsone and rifampicin. Serological studies have also yielded M. Leprae-specific antibodies, a method which, it is hoped, will be further developed as an aid to diagnosis and follow-up of treatment. Research concerning a leprosy vaccine is also in progress.
PY - 1990 SP - 338 EP - 9 T2 - Nordisk medicin TI - [Research in developing countries: will leprosy vaccine be produced in Nepal?]. VL - 105 SN - 0029-1420 ER -